Anni Lotte Kirstine Pedersen
Direktor/Vorstandsmitglied bei Ascendis Pharma Endocrinology Division A/S
Ursprung des Netzwerks ersten Grades von Anni Lotte Kirstine Pedersen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Ascendis Pharma Endocrinology Division A/S
 Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Ascendis Pharma Endocrinology Division A/S engages in pharmaceutical preparations. The company was founded on June 29, 2012 and is headquartered in Hellerup, Denmark.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anni Lotte Kirstine Pedersen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| GENMAB A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
| ORSTED A/S | Electric Utilities | Corporate Officer/Principal | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chairman | |
| University of Copenhagen | College/University | Graduate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder General Counsel | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman | |
| Paradis A/S | Chairman | ||
| EMF Industries A/S | Chief Executive Officer | ||
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman | |
| MWJ Invest AB | Chairman | ||
| Ascendis Pharma, Inc. | Director/Board Member | ||
Miwo Invest ApS
 Miwo Invest ApS Miscellaneous Commercial ServicesCommercial Services Miwo Invest ApS owns and manages shares and ownership interests in other companies, as well as run consulting business within strategic business development, business strategy, financing, and investment. The company was founded by Michael Wolff Jensen on January 28, 2014 and is headquartered in Charlottenlund, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Vanx ApS | Chairman | ||
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ascendis Pharma Bone Diseases A/S | Chief Executive Officer Chairman | ||
| Ascendis Pharma Ophthalmology Division A/S | Chairman | ||
| Ascendis Pharma Oncology Division A/S | Chairman | ||
| Hummingbird Bioscience Holdings Pte Ltd. | Chairman | ||
| Ascendis Pharma Growth Disorders AS | Chief Executive Officer Chairman | ||
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chairman |
Statistik
International
| Dänemark | 17 |
| Schweden | 6 |
| Vereinigte Staaten | 4 |
| China | 2 |
| Singapur | 2 |
Sektoral
| Health Technology | 13 |
| Commercial Services | 3 |
| Consumer Services | 3 |
| Finance | 2 |
| Utilities | 2 |
Operativ
| Chairman | 15 |
| Director/Board Member | 8 |
| Chief Executive Officer | 8 |
| Founder | 3 |
| President | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Wolff Jensen | 23 |
| Jan Mikkelsen | 13 |
- Börse
- Insiders
- Anni Lotte Kirstine Pedersen
- Unternehmensverbindungen
